Recombinant GTP-binding nuclear protein Ran

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant GTP-binding Nuclear Protein Ran

Recombinant GTP-binding nuclear protein Ran (Ran) is a genetically engineered version of the Ran GTPase, a critical regulatory protein involved in nucleocytoplasmic transport, mitotic spindle assembly, and nuclear envelope formation . Produced through heterologous expression systems, recombinant Ran retains the biochemical properties of native Ran, including GTP/GDP binding, hydrolysis, and interactions with effector proteins . Its applications span structural studies, in vitro transport assays, and investigations into cell cycle regulation .

Production and Purification

Recombinant Ran is typically expressed in E. coli or insect cell systems. Methods include:

  • Expression vectors: pET or baculovirus systems for high-yield production .

  • Purification: Affinity chromatography (e.g., His-tag) followed by gel filtration .

  • Nucleotide loading: Pre-loaded with non-hydrolysable GTP analogues (e.g., GppNHp) for structural studies .

Nucleotide Binding and Hydrolysis

  • GTP affinity: Ran binds GTP with a KdK_d of ~20 nM, which is 10-fold weaker than GDP due to its autoinhibitory C-terminal tail .

  • GTPase activity: Intrinsic hydrolysis rate is 2.1×105s12.1 \times 10^{-5} \, \text{s}^{-1}, accelerated 105^5-fold by RanGAP1 .

  • Nucleotide exchange: Catalyzed by RCC1, increasing GDP release by 105^5-fold .

Table 2: Kinetic Parameters of Recombinant Ran

ParameterValueConditionSource
kcatk_{\text{cat}} (GTP hydrolysis)2.1s12.1 \, \text{s}^{-1}RanGAP1-saturated
KdK_d (GDP binding)1.2nM1.2 \, \text{nM}Mg2+^{2+}-dependent
KdK_d (RanBP1 binding)3nM3 \, \text{nM}GTP-bound state

Mutant Variants and Functional Insights

  • RanQ69L: GTPase-deficient mutant used to study Ran- GTP effector interactions. Disrupts nuclear import by sequestering importins .

  • RanT24N: GDP-locked mutant inhibits RCC1-mediated nucleotide exchange, blocking nuclear assembly .

  • RanL182A: Increases GTP-bound Ran levels by destabilizing C-terminal autoinhibition, enhancing CRM1-mediated export .

Post-Translational Modifications

  • Acetylation at K71: Disrupts nuclear localization by preventing NTF2 binding, mimicking RanT24N effects .

  • Acetylation at K99: Reduces RCC1 affinity by 34-fold, impairing nucleotide exchange .

Table 3: Functional Impact of Ran Mutations

MutationNucleotide StateFunctional DefectKey Reference
Q69LGTP-lockedInhibits importin recycling
T24NGDP-lockedBlocks nuclear assembly and DNA replication
L182AGTP-stabilizedEnhances CRM1-dependent export
T42AEffector-bindingFails to bind RanBP1 or karyopherin-β

Applications in Research

  1. Nuclear Transport Assays: Reconstituted systems using recombinant Ran and permeabilized cells elucidate import/export mechanisms .

  2. Structural Biology: Crystallography of Ran- GppNHp complexes reveals switch region dynamics .

  3. Cancer Research: Mutants like RanL182A model GTPase dysregulation in tumors .

Challenges and Future Directions

  • Nucleotide-specific probes: Developing fluorescent analogs to track Ran- GTP/GDP gradients in live cells .

  • Therapeutic targeting: Screening for inhibitors of Ran-effector interactions in metastatic cancers .

Product Specs

Form
Lyophilized powder. We will ship the in-stock format by default. For specific format requirements, please note them during order placement.
Lead Time
Delivery times vary based on purchasing method and location. Consult your local distributor for specifics. All proteins ship with blue ice packs by default. For dry ice shipping, contact us in advance; extra fees apply.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you have a specific tag type requirement, please inform us and we will prioritize development accordingly.
Synonyms
; GTP-binding nuclear protein Ran; GTPase Ran; Ras-like protein TC4
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-214
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Plasmodium falciparum
Target Protein Sequence
MDSQEYIPQY KLILVGDGGV GKTTFVKRHL TGEFEKKYIP TLGVEVHPLK FQTNFGKTQF NVWDTAGQEK FGGLRDGYYI KSDCAIIMFD VSSRITYKNV PNWYRDITRV CETIPMVLVG NKVDVKDRQV KSRQIQFHRK RNLQYYDLSA RSNYNFEKPF LWLARRLSNQ PNLVFVGEHA KAPEFQIDLN IVREAEKELE QAAAVAIDEE DIEN
Uniprot No.

Target Background

Function
GTP-binding protein involved in nucleocytoplasmic transport. It is necessary for nuclear protein import and RNA export, and is also involved in chromatin condensation and cell cycle control.
Protein Families
Small GTPase superfamily, Ran family
Subcellular Location
Nucleus.

Q&A

Basic Research Questions

  • What is the structure and function of recombinant GTP-binding nuclear protein Ran?

    Ran is a small GTPase (approximately 25 kDa) belonging to the Ras superfamily. Structurally, it consists of a G-domain with a central six-stranded β-sheet surrounded by α-helices. Like other Ras family members, Ran binds GTP and GDP with high picomolar affinity. The protein undergoes significant conformational changes between GDP- and GTP-bound states, particularly in the switch I and switch II regions.

    Functionally, Ran regulates nucleo-cytoplasmic transport, nuclear envelope formation, mitotic spindle assembly, and participates in various cytosolic processes including interactions with the actin cytoskeleton. These diverse functions are primarily mediated through an intracellular Ran- GTP/Ran- GDP gradient established by the distinct subcellular localization of its regulators RCC1 (primarily nuclear) and RanGAP (primarily cytoplasmic) .

  • How can I express and purify recombinant Ran protein for research applications?

    Recombinant Ran can be expressed in bacterial systems such as E. coli using standard expression vectors. For purification, a typical approach involves:

    • Growth in appropriate media with induction at OD600 0.6-0.8

    • Cell lysis in buffer containing protease inhibitors

    • Affinity chromatography (if using tagged constructs)

    • Size-exclusion chromatography (SEC) for final purification

    For nucleotide exchange, incubate the purified protein with a 5-fold molar excess of non-hydrolyzable GTP analogs (GppNHp) or 80-fold excess of GDP/GTP in the presence of catalytic amounts of GST-RCC1. For loading non-hydrolyzable nucleotides, add calf intestinal phosphatase to hydrolyze residual GDP/GTP. Remove GST-RCC1 with glutathione-Sepharose beads and separate Ran from excess nucleotide by SEC. Verify nucleotide loading by HPLC .

  • What methods can be used to maintain Ran in a GTP-bound state for experimental studies?

    Several approaches are available for maintaining Ran in a GTP-bound state:

    1. Mutation of Q69L: This mutation impairs GTP hydrolysis, but typically results in only ~12% GTP-bound protein .

    2. C-terminal truncation: Ran 1-179 (missing the C-terminal region) shows ~87% GTP loading, while Ran 1-210 shows ~35% GTP loading. These truncations prevent the autoinhibitory effect of the C-tail .

    3. C-tail disrupting (C-dis) mutations: Recently developed mutations targeting the interaction between the C-tail and G-domain (A133D, L182A, and M189D) result in 79-85% GTP-bound Ran without requiring additional GTP or GTP analogs during purification .

    Ran Variant% GTP-boundNotes
    Wild-type6%Low GTP binding due to autoinhibition
    Q69L12%Hydrolysis-deficient mutant
    1-17987%C-terminal truncation
    1-21035%Partial C-terminal truncation
    A133D79-85%C-tail disrupting mutation
    L182A79-85%C-tail disrupting mutation
    M189D79-85%C-tail disrupting mutation
    Y197A23%Less critical for autoinhibition
  • How can I verify the nucleotide-bound state of recombinant Ran?

    Several approaches can confirm whether Ran is GDP- or GTP-bound:

    • HPLC analysis: Direct measurement of bound nucleotides after protein denaturation

    • RanBP1 binding assays: RanBP1 preferentially binds to RanGTP. Pull-down experiments with GST-RanBP1 will show stronger binding for GTP-bound Ran variants

    • Functional assays: Testing Ran's ability to form complexes with transport receptors such as CRM1 in the presence of cargo proteins containing nuclear export signals (NES)

    • Structural analysis: Circular dichroism or limited proteolysis can detect the conformational differences between GDP- and GTP-bound states

  • What are the key interaction partners of Ran and how can these interactions be studied?

    Key Ran interaction partners include:

    • RCC1: The guanine nucleotide exchange factor (GEF) that catalyzes GDP/GTP exchange

    • RanGAP: GTPase-activating protein that stimulates GTP hydrolysis

    • RanBP1/RanBP2: Ran-binding proteins that increase RanGAP activity

    • Importin-β: Forms import complexes with Ran

    • CRM1 (Exportin-1): Forms export complexes with Ran and cargo

    These interactions can be studied using:

    • Isothermal Titration Calorimetry (ITC): For measuring binding affinities, stoichiometry, and thermodynamic parameters. Typically performed in buffer containing 20-30 mM HEPES, 100-150 mM NaCl, 1-5 mM MgCl₂ at pH 7.4-7.5

    • Pull-down assays: Using GST-tagged binding partners to assess interaction with Ran variants

    • Surface Plasmon Resonance (SPR): For real-time binding kinetics

    • Co-immunoprecipitation: For cell-based interaction studies

Advanced Research Questions

  • How does lysine acetylation affect Ran function and what methodologies can be used to study this?

    Proteomic screens have identified multiple lysine acetylation sites in Ran, including positions in functionally important regions like the switch I and switch II domains. Acetylation affects several critical Ran functions:

    • RCC1-catalyzed nucleotide exchange: Acetylation at K37 moderately reduces, while K71 and K99 strongly reduce, nucleotide dissociation rates. K99 acetylation causes a nearly 10-fold reduction in exchange rate

    • Nucleotide hydrolysis: Acetylation at K71 increases the intrinsic hydrolysis rate by 1.5-fold (from 5.8 to 8.9 s⁻¹ at 37°C)

    • Interaction with regulators: K159 acetylation reduces RanBP1 affinity 10-fold for GTP-bound Ran, while K99 acetylation reduces RanGAP binding 34-fold when in complex with RanBP1

    • Transport receptor interactions: Acetylation at K37, K99, and K159 increases binding to Importin-β and enhances CRM1-mediated export complex formation

    To study acetylation effects, researchers can use the genetic code expansion concept to incorporate acetyl-lysine at specific positions. This involves:

    1. Using an orthogonal tRNA/aminoacyl-tRNA synthetase pair specific for acetyl-lysine

    2. Site-directed mutagenesis to incorporate the TAG codon at desired lysine positions

    3. Expression in the presence of acetyl-lysine

    4. Purification and functional characterization of the acetylated protein

  • What are the advantages and applications of C-tail disrupting Ran mutants?

    C-tail disrupting (C-dis) mutations in Ran have emerged as valuable tools for research by enabling efficient production of GTP-bound Ran. These mutations disrupt interactions between the C-terminal tail and the G-domain:

    Advantages of C-dis mutants:

    1. High GTP loading: 79-85% GTP-bound without requiring additional GTP during purification

    2. Structural stability: More stable than C-terminal truncations (Ran 1-179)

    3. Maintained functionality: Retain ability to bind RanBP1 and RanBP2

    4. Simplified purification: No need for costly GTP analogs or complex nucleotide exchange procedures

    Recommended applications:

    • Structural studies: The double-mutant Ran Q69L/L182A is particularly suitable for isothermal titration calorimetry experiments, allowing for accurate determination of RanGTP concentration

    • Nuclear export complex reconstitution: C-dis mutants enhance CRM1 binding to NES-containing cargo

    • In vitro functional assays: Provide a reliable source of GTP-bound Ran without RanGDP contamination

    MutationMechanism% GTP-boundUse Case
    A133DDisrupts G-domain/C-tail packing79-85%General studies requiring RanGTP
    L182ADisrupts insertion of L182 into G-domain cavity79-85%Enhanced CRM1 binding
    M189DDisrupts insertion of M189 into G-domain cavity79-85%General studies requiring RanGTP
    Q69L/L182ACombines hydrolysis defect with C-tail disruption>85%ITC studies requiring pure RanGTP
  • How can I quantitatively measure Ran's interactions with transport receptors and regulatory proteins?

    For rigorous quantitative analysis of Ran interactions, consider the following methodologies:

    Isothermal Titration Calorimetry (ITC):

    • Provides direct measurement of binding affinity (KD), stoichiometry (N), and thermodynamic parameters (ΔH, ΔS, ΔG)

    • Typical experimental setup: 2-3 μL of protein A (0.1-700 μM) injected into protein B (10-140 μM)

    • Buffer composition is crucial: typically performed in 20-30 mM HEPES, 100-150 mM NaCl, 1-5 mM MgCl₂, pH 7.4-7.5

    • For studying interactions with regulators like RanGAP that only bind in the presence of cofactors, preform complexes (e.g., Ran- GppNHp- RanBP1) before titration

    Example ITC data for Ran interactions:

    Ran VariantBinding PartnerKDΔH (kcal/mol)Notes
    Ran- GDPRanBP17.1 μM-Weaker binding in GDP state
    Ran- GppNHpRanBP13 nM-Strong binding in GTP state
    Ran- GppNHp AcK159RanBP133 nM-10-fold reduction from acetylation
    Ran- GppNHp- RanBP1RanGAP0.5 μM-Stoichiometry (N) of 0.5 when titrating RanGAP
    Ran- GppNHp- RanBP1 AcK99RanGAP17 μM-34-fold reduction from acetylation

    Stopped-flow kinetics:

    For measuring the dynamics of interactions and nucleotide exchange:

    • Load Ran with fluorescently labeled mantGDP (500 nM)

    • Mix with increasing concentrations of binding partner (e.g., RCC1 at 0.0195-40 μM)

    • Include excess unlabeled nucleotide (e.g., 25 μM GTP)

    • Fit primary data to single exponential function to obtain observed rate constants (kobs)

    • Plot kobs against binding partner concentration and fit to a hyperbolic function

  • What methodologies can be used to study the intrinsic and GAP-stimulated GTP hydrolysis by Ran?

    GTP hydrolysis by Ran can be studied through several approaches:

    Measuring intrinsic GTP hydrolysis:

    • The intrinsic GTP hydrolysis rate of Ran is very slow (5.4 × 10⁻⁵ s⁻¹ at 37°C) but can be measured using radioactive GTP (γ-³²P-GTP) or through HPLC-based methods

    • For modified Ran variants, compare hydrolysis rates under identical conditions to assess the impact of mutations or post-translational modifications

    • Example: Acetylation of K71 increases the intrinsic hydrolysis rate 1.5-fold (from 5.8 to 8.9 s⁻¹ at 37°C)

    GAP-stimulated hydrolysis:

    • RanGAP accelerates GTP hydrolysis approximately 10⁵-fold (to 2.1 s⁻¹ at 25°C)

    • Can be measured through stopped-flow fluorescence using mant-labeled GTP

    • Alternatively, use a phosphate-binding protein assay to detect released inorganic phosphate

    • Consider the influence of cofactors: RanBP1 increases RanGAP affinity for Ran- GTP from 7 μM to 2 μM

    RanBP1 effects on GAP activity:

    • To measure GAP-mediated hydrolysis in the presence of RanBP1, preform Ran- GTP- RanBP1 complexes before adding RanGAP

    • This approach allows assessment of how modifications affect GAP activity in physiologically relevant complexes

    • Example: While acetylation of K99 reduces RanGAP binding to the Ran- RanBP1 complex, it does not affect the rate of GAP-mediated GTP hydrolysis in this context

  • How can I investigate the effects of post-translational modifications on Ran localization and transport function?

    Post-translational modifications, particularly lysine acetylation, can significantly impact Ran localization and transport functions. For comprehensive investigation:

    Subcellular localization studies:

    • Express fluorescently tagged Ran variants (wild-type or modified) in cells

    • Use confocal microscopy to assess nuclear/cytoplasmic distribution

    • Example: Acetylation or mutation of K71 disrupts two salt bridges to D92 and D94 of NTF2, preventing nuclear Ran localization

    • K99 modification may also affect nuclear localization through an unknown NTF2-independent mechanism

    Transport assays:

    • Nuclear import: Use fluorescently tagged import cargoes and measure their accumulation in the nucleus

    • Nuclear export: Monitor the export of NES-containing proteins from the nucleus

    • Compare kinetics between wild-type and modified Ran variants

    • Example: Acetylation of Ran at K37, K99, and K159 increases binding toward Importin-β, primarily through decreased complex dissociation rates

    Export complex formation:

    • Test the ability of modified Ran to form functional export complexes with CRM1 and cargo

    • Pull-down assays with GST-tagged NES-containing proteins can assess complex formation

    • Example: The C-dis mutant Ran L182A dose-dependently enhances CRM1 binding to GST-tagged NES

    • Acetylation of K37, K99, and K159 increases the binding of export cargo (Spn1) to preformed CRM1- Ran- GppNHp complexes

    Functional implications model:

    Based on available research, acetylation of Ran may support import substrate release in the nucleus and enhance subsequent nuclear export cargo binding. The effects on various Ran interactions can fine-tune cellular processes, with accumulated acetylation potentially having significant consequences for Ran localization, the Ran- GTP/GDP gradient, and transport processes .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.